Where to purchase sirolimus albumin-bound nanoparticle injection (FYARRO)

Sirolimus albumin-bound nanoparticle injection (FYARRO) administered intravenously is indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa). Sirolimus albumin-bound nanoparticle injection is a white to yellow sterile freeze-dried powder, used for reconstitution with 20mL 0.9% sodium chloride injection before intravenous infusion. is an albumin-bound nanoparticle of sirolimus. The most important active ingredient is sirolimus (sirolimus) bound to albumin. Albumin exists in the nanoparticles in a non-crystalline and amorphous state. Perivascular epithelioid cell tumor is a rare sarcoma caused by mTOR activation. Sirolimus binds to human albumin and achieves higher accumulation in solid tumors; albumin accumulates in tumor tissue, either due to leakage in the capillary system and defects in tumor lymphatic drainage, or through active gp60/caveolae-mediated transport across the tumor vascular endothelium.

The original drug of sirolimus albumin-bound nanoparticle injection is a new type of drug for treating diseases. It is not yet on the market in China, so it is not included in medical insurance. Domestic patients cannot yet purchase this drug. The common dosage form of sirolimus albumin-bound nanoparticle injection original drug is injection, which has been marketed overseas. US version specifications The price of each 100mg tube may be around RMB 60,000 (the price may fluctuate due to the exchange rate), which is relatively expensive. Currently, there is no generic version of Sirolimus Albumin-Bound Nanoparticle Injection on the market. For more drug information and specific prices, please consult Yaode Medical Consultants.